Fig. 1From: Downregulated TICAM1 is a prognostic biomarker and associated with immune tolerance of Wilms tumor patientsExpression level of TICAM1. TICAM1 expression level analysis in pan-cancer (A). TICAM1 expression in WT and normal tissue in TARGET cohort (B). TICAM1 paired expression analysis in WT and normal tissue in TARGET cohort (C). TICAM1 expression in external validation set GSE66405 (D)Back to article page